title: No local recurrence of enchondroma after curettage and plaster filling.
abstract: BACKGROUND
  The most common treatment of enchondromas is curettage (with or without adjuvant therapy) followed by cancellous bone grafting. To avoid donor-site morbidity of the iliac crest, we applied plaster of Paris as a bone defect filler after curettage of enchondromas.
  
  
  METHODS
  We treated 19 enchondromas of the hand and foot in 19 patients (mean age 40 years, range 21-79 years) with curettage and filling of the cavity with sterile plaster of Paris (calcium sulphate/phosphate) tablets.
  
  
  RESULTS
  The diagnosis was histologically confirmed in all cases. After a mean follow-up of 53 months (range 15-139 months), the mean functional Muskuloskeletal Tumor Society Score was 29.1 points (97%; range 28-30). There were no local recurrences although adjuvant therapy was not utilized.
  
  
  CONCLUSIONS
  Plaster of Paris appears safe and effective as a bone-filling substance after curettage of enchondroma.
authors.affiliation: Department of Orthopaedic Surgery, Rijnstate Hospital, P.O. Box 9555, 6800 TA, Arnhem, The Netherlands. robert_gaasbeek@hetnet.nl
authors.forename: R D A
authors.initials: RD
authors.lastname: Gaasbeek
authors.forename: W J
authors.initials: WJ
authors.lastname: Rijnberg
authors.forename: C J M
authors.initials: CJ
authors.lastname: van Loon
authors.forename: H
authors.initials: H
authors.lastname: Meyers
authors.forename: R
authors.initials: R
authors.lastname: Feith
mesh_terms: D000328:Adult; D000368:Aged; D001859:Bone Neoplasms / Q000601:surgery*; D018786:Bone Substitutes / Q000627:therapeutic use*; D002133:Calcium Sulfate / Q000627:therapeutic use*; D002812:Chondroma / Q000601:surgery*; D003475:Curettage; D005260:Female; D005500:Follow-Up Studies; D005528:Foot / Q000601:surgery; D006225:Hand / Q000601:surgery; D006801:Humans; D008297:Male; D008875:Middle Aged; D013607:Tablets; D016896:Treatment Outcome
chemical_list: D018786:Bone Substitutes; D013607:Tablets; D002133:Calcium Sulfate